Soleno Therapeutics, Inc.SLNONASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$28.38M
↑ 191% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
$-31.03M
Historical baseline
PeriodValueYoY Change
TTM$28.38M+116.3%
2024$-173.63M-368.9%
2023$-37.03M-67.5%
2022$-22.10M+27.0%
2021$-30.30M-35.0%
2020$-22.45M+21.2%
2019$-28.48M-187.0%
2018$-9.92M-23.0%
2017$-8.07M-20.1%
2016$-6.72M-